SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-152536
Filing Date
2024-06-03
Accepted
2024-06-03 09:13:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d820108d424b5.htm 424B5 543410
2 GRAPHIC g811721g11a11.jpg GRAPHIC 13415
3 GRAPHIC g820108g01a01.jpg GRAPHIC 15138
4 GRAPHIC g820108g45a45.jpg GRAPHIC 47487
  Complete submission text file 0001193125-24-152536.txt   650176
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279905 | Film No.: 241012190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 212-883-0200
Royalty Pharma Holdings Ltd. (Filer) CIK: 0001868134 (see all company filings)

IRS No.: 981526515 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279905-01 | Film No.: 241012191